These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21945679)

  • 1. Facilitated intracellular delivery of peptide-guided nanoparticles in tumor tissues.
    Kim JH; Bae SM; Na MH; Shin H; Yang YJ; Min KH; Choi KY; Kim K; Park RW; Kwon IC; Lee BH; Hoffman AS; Kim IS
    J Control Release; 2012 Feb; 157(3):493-9. PubMed ID: 21945679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
    Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
    J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
    Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
    J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel.
    Kim JH; Kim YS; Kim S; Park JH; Kim K; Choi K; Chung H; Jeong SY; Park RW; Kim IS; Kwon IC
    J Control Release; 2006 Mar; 111(1-2):228-34. PubMed ID: 16458988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
    Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
    J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
    Hwang HY; Kim IS; Kwon IC; Kim YH
    J Control Release; 2008 May; 128(1):23-31. PubMed ID: 18374444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted paclitaxel nanoparticles modified with follicle-stimulating hormone β 81-95 peptide show effective antitumor activity against ovarian carcinoma.
    Zhang X; Chen J; Kang Y; Hong S; Zheng Y; Sun H; Xu C
    Int J Pharm; 2013 Sep; 453(2):498-505. PubMed ID: 23811008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of the targeting capabilities of the Paclitaxel-loaded pluronic nanoparticles with a glycol chitosan/heparin composite.
    Yuk SH; Oh KS; Cho SH; Kim SY; Oh S; Lee JH; Kim K; Kwon IC
    Mol Pharm; 2012 Feb; 9(2):230-6. PubMed ID: 22149139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the stability and deformability of self-assembled glycol chitosan nanoparticles on tumor-targeting efficiency.
    Na JH; Lee SY; Lee S; Koo H; Min KH; Jeong SY; Yuk SH; Kim K; Kwon IC
    J Control Release; 2012 Oct; 163(1):2-9. PubMed ID: 22846988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration.
    Lv PP; Wei W; Yue H; Yang TY; Wang LY; Ma GH
    Biomacromolecules; 2011 Dec; 12(12):4230-9. PubMed ID: 22044456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles.
    Nam HY; Kwon SM; Chung H; Lee SY; Kwon SH; Jeon H; Kim Y; Park JH; Kim J; Her S; Oh YK; Kwon IC; Kim K; Jeong SY
    J Control Release; 2009 May; 135(3):259-67. PubMed ID: 19331853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrotropic oligomer-conjugated glycol chitosan as a carrier of paclitaxel: synthesis, characterization, and in vivo biodistribution.
    Saravanakumar G; Min KH; Min DS; Kim AY; Lee CM; Cho YW; Lee SC; Kim K; Jeong SY; Park K; Park JH; Kwon IC
    J Control Release; 2009 Dec; 140(3):210-7. PubMed ID: 19560497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy.
    Kim JH; Kim YS; Park K; Kang E; Lee S; Nam HY; Kim K; Park JH; Chi DY; Park RW; Kim IS; Choi K; Chan Kwon I
    Biomaterials; 2008 Apr; 29(12):1920-30. PubMed ID: 18289669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-pool multifunctional nanoparticles formed by temperature-induced phase transition for cancer-targeting therapy and molecular imaging.
    Oh KS; Lee S; Na JH; Kim JY; Kim DE; Kim K; Kwon IC; Yuk SH; Jeong SY
    Int J Pharm; 2012 Nov; 437(1-2):192-202. PubMed ID: 22944301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional drug delivery system for targeting tumor and its acidic microenvironment.
    Shen M; Huang Y; Han L; Qin J; Fang X; Wang J; Yang VC
    J Control Release; 2012 Aug; 161(3):884-92. PubMed ID: 22587941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An arginine derivative contained nanostructure lipid carriers with pH-sensitive membranolytic capability for lysosomolytic anti-cancer drug delivery.
    Li S; Su Z; Sun M; Xiao Y; Cao F; Huang A; Li H; Ping Q; Zhang C
    Int J Pharm; 2012 Oct; 436(1-2):248-57. PubMed ID: 22732672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shell-crosslinked hybrid nanoparticles for direct cytosolic delivery for tumor therapy.
    He W; Jin Z; Lv Y; Cao H; Yao J; Zhou J; Yin L
    Int J Pharm; 2015 Jan; 478(2):762-72. PubMed ID: 25529435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-time and non-invasive optical imaging of tumor-targeting glycol chitosan nanoparticles in various tumor models.
    Na JH; Koo H; Lee S; Min KH; Park K; Yoo H; Lee SH; Park JH; Kwon IC; Jeong SY; Kim K
    Biomaterials; 2011 Aug; 32(22):5252-61. PubMed ID: 21513975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles.
    Park K; Kim JH; Nam YS; Lee S; Nam HY; Kim K; Park JH; Kim IS; Choi K; Kim SY; Kwon IC
    J Control Release; 2007 Oct; 122(3):305-14. PubMed ID: 17643545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.